Funded Grants

Malignant gliomas, including oligodendrogliomas (OD) and glioblastomas (GBM), are currently incurable brain tumours with few effective treatment options.

To improve outcomes in brain cancer, better tools are needed to diagnose brain cancer, surgically remove brain tumours and monitor how they respond to therapy.

Autism spectrum disorders (ASD) and schizophrenia (SZ) are two psychiatric conditions that affect approximately 2% of the general population. Genetic studies have identified mutations in hundreds of genes associated with ASD and SZ.

A substantial proportion of individuals are left with poor residual functioning of the affected arm after a stroke.

One of the most important questions of biomedical research is “why do we ail as we age?”.

Alzheimer’s Disease (AD) is a severe dementia that is likely a result of years of buildup in the brain of molecules called amyloid-beta oligomers (AβOs).

Ms. Raza’s research focuses on early development in autism spectrum disorder (ASD), with the goal of identifying behavioral and physiological markers in at-risk infants.

Dr. Xie’s research focuses on the functional assessment of neuropsychiatric disease related synaptic genes – MDGA1 and 2. MDGAs bind to critical neuron synaptic proteins – Neuroglin (NLGN), disrupting the binding between NLGN and Neurexin (NRXN), so suppressing synaptogenesis.

The project provides state of the art mouse brain imaging to researchers in Canada working on models of neurodevelopmental disorders.

The overarching aim of Ms Morena’s research is to investigate the role of the endocannabinoid system in the modulation of memory processes and its interaction with stress and emotional arousal in animal models of cognition, at a cellular, circuit and behavioural level.